A

Amyris Inc
F:3A01

Watchlist Manager
Amyris Inc
F:3A01
Watchlist
Price: 0.0391 EUR Market Closed
Market Cap: €14.4m

Net Margin

-269.4%
Current
Declining
by 40.3%
vs 3-y average of -229%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-269.4%
=
Net Income
$-614.5m
/
Revenue
$268.2m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-269.4%
=
Net Income
€-614.5m
/
Revenue
$268.2m

Peer Comparison

Country Company Market Cap Net
Margin
US
Amyris Inc
F:3A01
14.4m EUR
Loading...
US
Sherwin-Williams Co
NYSE:SHW
85.9B USD
Loading...
US
Ecolab Inc
NYSE:ECL
79.9B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.5T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
263.7B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
29B CHF
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.6T INR
Loading...
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
PPG Industries Inc
NYSE:PPG
25B USD
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
US
Albemarle Corp
NYSE:ALB
22.4B USD
Loading...

Market Distribution

Lower than 90% of companies in the United States of America
Percentile
10th
Based on 15 072 companies
10th percentile
-269.4%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Amyris Inc
Glance View

Market Cap
14.4m EUR
Industry
Chemicals

Amyris, Inc. engages in the provision of bioscience solutions. The company is headquartered in Emeryville, California and currently employs 980 full-time employees. The company went IPO on 2010-09-28. The firm applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The firm's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The firm is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance. Its brands include Biofene, Hemisqualane, Biossance, clean beauty skincare, Pipette, clean baby skincare and Purecane.

3A01 Intrinsic Value
Not Available
A
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-269.4%
=
Net Income
$-614.5m
/
Revenue
$268.2m
What is Amyris Inc's current Net Margin?

The current Net Margin for Amyris Inc is -269.4%, which is below its 3-year median of -229%.

How has Net Margin changed over time?

Over the last 3 years, Amyris Inc’s Net Margin has decreased from -193.4% to -269.4%. During this period, it reached a low of -307.3% on Sep 30, 2020 and a high of -94.7% on Jun 30, 2022.

Back to Top